Triclosan kills bacteria through two distinct mechanisms depending on its concentration. At low levels, it blocks a specific enzyme bacteria need to build their cell membranes. At high levels, it physically damages those membranes directly. This dual action made triclosan one of the most widely used antimicrobial agents in consumer products for decades, though regulatory concerns have significantly narrowed its use since 2017.
The Primary Target: Fatty Acid Synthesis
Bacteria constantly build and repair their cell membranes, and they need fatty acids to do it. Triclosan works by locking onto a key enzyme in the fatty acid production line called enoyl-acyl carrier protein reductase, or FabI. This enzyme handles one of the final steps in each cycle of fatty acid construction. When triclosan binds to FabI, it essentially jams the machinery, and bacteria can no longer produce the membrane components they need to grow and divide.
What makes triclosan especially effective at this job is the way it binds. Rather than simply blocking the enzyme’s active site, triclosan wedges itself between the enzyme and a helper molecule (a cofactor) that the enzyme needs to function. This creates an extremely stable three-part complex. The hydrogen bonds and hydrophobic interactions holding this complex together make it very difficult for the enzyme to shake free, which is why triclosan remains effective at remarkably low concentrations. Researchers at Washington University confirmed this structure using X-ray crystallography, showing that triclosan sits right where the enzyme’s normal substrate would go.
At these low concentrations, triclosan is bacteriostatic: it prevents bacteria from multiplying without outright killing them. The bacteria are alive but unable to grow because they can’t manufacture new membrane material. Over time, existing bacteria die off naturally while no new ones replace them.
Membrane Destruction at Higher Concentrations
Consumer products like soaps and toothpastes contain triclosan at concentrations far above what’s needed to inhibit FabI. Some commercial formulations contain triclosan at concentrations as high as 17 millimolar, well into bactericidal territory. At these levels, triclosan doesn’t just block an enzyme. It physically inserts itself into the bacterial cell membrane.
Nuclear magnetic resonance imaging has shown exactly how this works. Triclosan molecules slip into the fatty, hydrophobic pockets within the membrane’s lipid bilayer, positioning themselves perpendicular to the phospholipid molecules that form the membrane’s structure. This intercalation introduces defects throughout the membrane, compromising its integrity. Think of it like forcing extra cards into a carefully stacked house of cards. The membrane loses its ability to regulate what enters and exits the cell, and the bacterium dies. At these concentrations, the cell membrane itself is the primary target, and the effect is direct killing rather than growth inhibition.
Which Bacteria Are Affected
Triclosan is classified as a broad-spectrum antimicrobial, meaning it works against a wide range of bacterial species. It is effective against both gram-positive bacteria (like Streptococci and Actinomyces) and gram-negative species. It also shows activity against anaerobic bacteria, Fusobacteria, and biofilms, which are the sticky colonies that bacteria form on surfaces like teeth and medical devices.
Not all bacteria are equally vulnerable, though. Species that naturally lack the FabI enzyme or have alternative fatty acid synthesis pathways can tolerate triclosan more easily. Pseudomonas aeruginosa, a common hospital pathogen, has inherent mechanisms that reduce triclosan’s effectiveness. The minimum concentration needed to inhibit growth varies by species. For Enterococcus faecalis, a bacterium associated with urinary and wound infections, the minimum inhibitory concentration is around 3.4 micrograms per milliliter, which is comparable to the antibiotic amoxicillin against the same organism.
How Bacteria Develop Resistance
Bacteria have evolved two main strategies to survive triclosan exposure. The first involves efflux pumps: protein channels in the cell membrane that actively eject triclosan before it can accumulate inside the cell. Research on E. coli has shown that resistant strains dramatically increase production of these pumps. Some efflux pump genes were upregulated by more than 18-fold in resistant strains compared to susceptible ones. This pump-it-out strategy is particularly concerning because the same efflux systems can expel clinical antibiotics too.
The second resistance strategy targets the FabI enzyme itself. Some bacteria produce excess FabI, essentially flooding the cell with so much enzyme that triclosan can’t block it all. Others acquire mutations in the FabI active site that prevent the stable three-part complex from forming properly, allowing fatty acid synthesis to continue even in triclosan’s presence. In practice, resistant bacterial strains often use both strategies simultaneously.
The Cross-Resistance Problem
The efflux pump mechanism raises a serious concern: bacteria that become resistant to triclosan may simultaneously become harder to treat with medical antibiotics. This isn’t theoretical. A survey of 732 clinical isolates of Acinetobacter baumannii from hospitals found that strains tolerating higher triclosan concentrations also showed increased tolerance to multiple antibiotics, including tetracycline, levofloxacin, and imipenem. In Pseudomonas aeruginosa, triclosan exposure selected for mutations that boosted efflux systems, increasing tolerance to ciprofloxacin, tetracycline, erythromycin, and gentamicin. Salmonella strains cultured with daily triclosan exposure developed resistance to ampicillin, tetracycline, and kanamycin.
The pattern is consistent across species: because triclosan resistance and antibiotic resistance can share the same efflux machinery, exposure to one can drive resistance to the other.
Where Triclosan Is Still Used
These resistance concerns, combined with questions about endocrine effects, led the FDA to ban triclosan from consumer hand soaps and body washes effective September 6, 2017. The agency determined that manufacturers had not demonstrated that triclosan in these rinse-off products was either safe for long-term use or more effective than plain soap and water. The ban applies specifically to over-the-counter consumer antiseptic wash products used with water and rinsed off.
Triclosan remains permitted in other products, most notably toothpaste. A Cochrane review found that triclosan-containing toothpaste reduced both plaque and gum inflammation by 22% compared to standard fluoride toothpaste. This measurable clinical benefit in a product that isn’t rinsed off immediately, and that targets the specific oral bacteria responsible for gum disease, is the reason triclosan has maintained its foothold in dental care even as it has disappeared from most other consumer products.
Environmental Persistence
When triclosan washes down the drain, conventional wastewater treatment plants remove roughly 97 to 99% of it. That sounds thorough, but given the sheer volume of triclosan entering wastewater systems, measurable amounts still reach waterways. Effluent from treatment plants contains an average of about 8 nanograms per liter. A more significant reservoir is sewage sludge, which absorbs 36 to 49% of incoming triclosan and can concentrate it to over 800 nanograms per gram. When that sludge is applied to agricultural land as fertilizer, triclosan re-enters the environment and can expose soil bacteria to sub-lethal concentrations, precisely the conditions that promote resistance development.